HEADER MEMBRANE PROTEIN 23-JAN-23 8C9W TITLE CRYSTAL STRUCTURE OF THE ADENOSINE A2A RECEPTOR (CONSTRUCT A2A-PSB2- TITLE 2 BRIL) COMPLEXED WITH ETRUMADENANT AT THE ORTHOSTERIC POCKET COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYTOCHROME B-562; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: ADORA2A, ADORA2, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, BRIL, ANTAGONIST, PURINERGIC SIGNALING, CANCER IMMUNOTHERAPY, KEYWDS 2 MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.STRATER,T.CLAFF,J.G.SCHLEGEL,J.H.VOSS,V.VAASSEN,C.E.MULLER REVDAT 2 31-JAN-24 8C9W 1 AUTHOR REVDAT 1 12-JUL-23 8C9W 0 JRNL AUTH T.CLAFF,J.G.SCHLEGEL,J.H.VOSS,V.J.VAASSEN,R.H.WEISSE, JRNL AUTH 2 R.K.Y.CHENG,S.MARKOVIC-MUELLER,D.BUCHER,N.STRATER,C.E.MULLER JRNL TITL CRYSTAL STRUCTURE OF ADENOSINE A 2A RECEPTOR IN COMPLEX WITH JRNL TITL 2 CLINICAL CANDIDATE ETRUMADENANT REVEALS UNPRECEDENTED JRNL TITL 3 ANTAGONIST INTERACTION. JRNL REF COMMUN CHEM V. 6 106 2023 JRNL REFN ESSN 2399-3669 JRNL PMID 37264098 JRNL DOI 10.1038/S42004-023-00894-6 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 74.8 REMARK 3 NUMBER OF REFLECTIONS : 21405 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.640 REMARK 3 FREE R VALUE TEST SET COUNT : 994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.2400 - 4.0400 0.99 4070 210 0.1866 0.2554 REMARK 3 2 4.0400 - 3.2100 1.00 3915 189 0.1847 0.2409 REMARK 3 3 3.2100 - 2.8000 1.00 3876 192 0.2046 0.2932 REMARK 3 4 2.8000 - 2.5500 0.99 3839 169 0.2138 0.2829 REMARK 3 5 2.5500 - 2.3700 0.80 3114 140 0.2259 0.2952 REMARK 3 6 2.3700 - 2.2300 0.36 1347 80 0.2520 0.3361 REMARK 3 7 2.2300 - 2.1140 0.07 250 14 0.3298 0.5429 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 3393 REMARK 3 ANGLE : 1.305 4599 REMARK 3 CHIRALITY : 0.052 532 REMARK 3 PLANARITY : 0.008 583 REMARK 3 DIHEDRAL : 14.504 1317 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8C9W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1292128118. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P14 (MX2) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97625 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS FEB 5, 2021 (BUILT 20210323) REMARK 200 DATA SCALING SOFTWARE : STARANISO 2.3.74 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21413 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.114 REMARK 200 RESOLUTION RANGE LOW (A) : 38.243 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 74.8 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.69700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: PHENIX 1.20_4459 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30 % (W/V) PEG400, 7 % (W/V) TACSIMATE REMARK 280 PH 7.0,100 MM HEPES-NA PH 7.4, 1.8 % (W/V) 2,5-HEXANDIOL, 25 REMARK 280 MICROM ETRUMADENANT, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.79750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.79750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 19.57750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 89.11300 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 19.57750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 89.11300 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 69.79750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 19.57750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 89.11300 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.79750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 19.57750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 89.11300 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -8 REMARK 465 TYR A -7 REMARK 465 LYS A -6 REMARK 465 ASP A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ALA A 1043 REMARK 465 THR A 1044 REMARK 465 PRO A 1045 REMARK 465 PRO A 1046 REMARK 465 LYS A 1047 REMARK 465 LEU A 1048 REMARK 465 GLU A 1049 REMARK 465 ASP A 1050 REMARK 465 LYS A 1051 REMARK 465 SER A 1052 REMARK 465 PRO A 1053 REMARK 465 ASP A 1054 REMARK 465 SER A 1055 REMARK 465 PRO A 1056 REMARK 465 GLU A 1057 REMARK 465 MET A 1058 REMARK 465 LYS A 1059 REMARK 465 ASP A 1060 REMARK 465 LEU A 308 REMARK 465 ARG A 309 REMARK 465 GLN A 310 REMARK 465 GLN A 311 REMARK 465 GLU A 312 REMARK 465 PRO A 313 REMARK 465 PHE A 314 REMARK 465 LYS A 315 REMARK 465 ALA A 316 REMARK 465 HIS A 317 REMARK 465 HIS A 318 REMARK 465 HIS A 319 REMARK 465 HIS A 320 REMARK 465 HIS A 321 REMARK 465 HIS A 322 REMARK 465 HIS A 323 REMARK 465 HIS A 324 REMARK 465 HIS A 325 REMARK 465 HIS A 326 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H GLY A 160 OE1 GLN A 163 1.49 REMARK 500 OE1 GLN A 1071 HG1 THR A 1097 1.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 186 -57.53 -121.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 1205 REMARK 610 OLA A 1206 REMARK 610 OLA A 1207 REMARK 610 OLC A 1209 REMARK 610 OLB A 1210 REMARK 610 OLC A 1211 REMARK 610 OLA A 1213 DBREF 8C9W A 2 208 UNP P29274 AA2AR_HUMAN 2 208 DBREF 8C9W A 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 8C9W A 219 316 UNP P29274 AA2AR_HUMAN 219 316 SEQADV 8C9W ASP A -8 UNP P29274 EXPRESSION TAG SEQADV 8C9W TYR A -7 UNP P29274 EXPRESSION TAG SEQADV 8C9W LYS A -6 UNP P29274 EXPRESSION TAG SEQADV 8C9W ASP A -5 UNP P29274 EXPRESSION TAG SEQADV 8C9W ASP A -4 UNP P29274 EXPRESSION TAG SEQADV 8C9W ASP A -3 UNP P29274 EXPRESSION TAG SEQADV 8C9W ASP A -2 UNP P29274 EXPRESSION TAG SEQADV 8C9W GLY A -1 UNP P29274 EXPRESSION TAG SEQADV 8C9W ALA A 0 UNP P29274 EXPRESSION TAG SEQADV 8C9W PRO A 1 UNP P29274 EXPRESSION TAG SEQADV 8C9W LYS A 91 UNP P29274 SER 91 CONFLICT SEQADV 8C9W ALA A 154 UNP P29274 ASN 154 CONFLICT SEQADV 8C9W TRP A 1007 UNP P0ABE7 MET 29 CONFLICT SEQADV 8C9W ILE A 1102 UNP P0ABE7 HIS 124 CONFLICT SEQADV 8C9W LEU A 1106 UNP P0ABE7 ARG 128 CONFLICT SEQADV 8C9W HIS A 317 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 318 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 319 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 320 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 321 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 322 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 323 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 324 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 325 UNP P29274 EXPRESSION TAG SEQADV 8C9W HIS A 326 UNP P29274 EXPRESSION TAG SEQRES 1 A 431 ASP TYR LYS ASP ASP ASP ASP GLY ALA PRO PRO ILE MET SEQRES 2 A 431 GLY SER SER VAL TYR ILE THR VAL GLU LEU ALA ILE ALA SEQRES 3 A 431 VAL LEU ALA ILE LEU GLY ASN VAL LEU VAL CYS TRP ALA SEQRES 4 A 431 VAL TRP LEU ASN SER ASN LEU GLN ASN VAL THR ASN TYR SEQRES 5 A 431 PHE VAL VAL SER LEU ALA ALA ALA ASP ILE ALA VAL GLY SEQRES 6 A 431 VAL LEU ALA ILE PRO PHE ALA ILE THR ILE SER THR GLY SEQRES 7 A 431 PHE CYS ALA ALA CYS HIS GLY CYS LEU PHE ILE ALA CYS SEQRES 8 A 431 PHE VAL LEU VAL LEU THR GLN SER LYS ILE PHE SER LEU SEQRES 9 A 431 LEU ALA ILE ALA ILE ASP ARG TYR ILE ALA ILE ARG ILE SEQRES 10 A 431 PRO LEU ARG TYR ASN GLY LEU VAL THR GLY THR ARG ALA SEQRES 11 A 431 LYS GLY ILE ILE ALA ILE CYS TRP VAL LEU SER PHE ALA SEQRES 12 A 431 ILE GLY LEU THR PRO MET LEU GLY TRP ASN ASN CYS GLY SEQRES 13 A 431 GLN PRO LYS GLU GLY LYS ALA HIS SER GLN GLY CYS GLY SEQRES 14 A 431 GLU GLY GLN VAL ALA CYS LEU PHE GLU ASP VAL VAL PRO SEQRES 15 A 431 MET ASN TYR MET VAL TYR PHE ASN PHE PHE ALA CYS VAL SEQRES 16 A 431 LEU VAL PRO LEU LEU LEU MET LEU GLY VAL TYR LEU ARG SEQRES 17 A 431 ILE PHE LEU ALA ALA ARG ARG GLN LEU ALA ASP LEU GLU SEQRES 18 A 431 ASP ASN TRP GLU THR LEU ASN ASP ASN LEU LYS VAL ILE SEQRES 19 A 431 GLU LYS ALA ASP ASN ALA ALA GLN VAL LYS ASP ALA LEU SEQRES 20 A 431 THR LYS MET ARG ALA ALA ALA LEU ASP ALA GLN LYS ALA SEQRES 21 A 431 THR PRO PRO LYS LEU GLU ASP LYS SER PRO ASP SER PRO SEQRES 22 A 431 GLU MET LYS ASP PHE ARG HIS GLY PHE ASP ILE LEU VAL SEQRES 23 A 431 GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN GLU GLY SEQRES 24 A 431 LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN LEU LYS SEQRES 25 A 431 THR THR ARG ASN ALA TYR ILE GLN LYS TYR LEU GLU ARG SEQRES 26 A 431 ALA ARG SER THR LEU GLN LYS GLU VAL HIS ALA ALA LYS SEQRES 27 A 431 SER LEU ALA ILE ILE VAL GLY LEU PHE ALA LEU CYS TRP SEQRES 28 A 431 LEU PRO LEU HIS ILE ILE ASN CYS PHE THR PHE PHE CYS SEQRES 29 A 431 PRO ASP CYS SER HIS ALA PRO LEU TRP LEU MET TYR LEU SEQRES 30 A 431 ALA ILE VAL LEU SER HIS THR ASN SER VAL VAL ASN PRO SEQRES 31 A 431 PHE ILE TYR ALA TYR ARG ILE ARG GLU PHE ARG GLN THR SEQRES 32 A 431 PHE ARG LYS ILE ILE ARG SER HIS VAL LEU ARG GLN GLN SEQRES 33 A 431 GLU PRO PHE LYS ALA HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 34 A 431 HIS HIS HET U30 A1201 54 HET CLR A1202 74 HET CLR A1203 74 HET CLR A1204 74 HET OLA A1205 15 HET OLA A1206 17 HET OLA A1207 9 HET OLA A1208 20 HET OLC A1209 22 HET OLB A1210 18 HET OLC A1211 16 HET PEG A1212 7 HET OLA A1213 19 HETNAM U30 3-[2-AZANYL-6-[1-[[6-(2-OXIDANYLPROPAN-2-YL)PYRIDIN-2- HETNAM 2 U30 YL]METHYL]-1,2,3-TRIAZOL-4-YL]PYRIMIDIN-4-YL]-2- HETNAM 3 U30 METHYL-BENZENECARBONITRILE HETNAM CLR CHOLESTEROL HETNAM OLA OLEIC ACID HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLB (2S)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 U30 C23 H22 N8 O FORMUL 3 CLR 3(C27 H46 O) FORMUL 6 OLA 5(C18 H34 O2) FORMUL 10 OLC 2(C21 H40 O4) FORMUL 11 OLB C21 H40 O4 FORMUL 13 PEG C4 H10 O3 FORMUL 15 HOH *57(H2 O) HELIX 1 AA1 PRO A 1 ASN A 34 1 34 HELIX 2 AA2 SER A 35 GLN A 38 5 4 HELIX 3 AA3 ASN A 39 LEU A 58 1 20 HELIX 4 AA4 LEU A 58 SER A 67 1 10 HELIX 5 AA5 CYS A 74 ILE A 108 1 35 HELIX 6 AA6 ARG A 111 VAL A 116 1 6 HELIX 7 AA7 THR A 117 LEU A 137 1 21 HELIX 8 AA8 THR A 138 GLY A 142 5 5 HELIX 9 AA9 LYS A 150 GLN A 157 1 8 HELIX 10 AB1 LEU A 167 VAL A 172 1 6 HELIX 11 AB2 PRO A 173 PHE A 180 1 8 HELIX 12 AB3 VAL A 186 LYS A 1019 1 42 HELIX 13 AB4 ASN A 1022 LYS A 1042 1 21 HELIX 14 AB5 ARG A 1062 GLU A 1081 1 20 HELIX 15 AB6 LYS A 1083 TYR A 1101 1 19 HELIX 16 AB7 TYR A 1101 CYS A 259 1 47 HELIX 17 AB8 PRO A 266 ILE A 292 1 27 HELIX 18 AB9 ILE A 292 HIS A 306 1 15 SHEET 1 AA1 2 CYS A 71 ALA A 73 0 SHEET 2 AA1 2 GLN A 163 ALA A 165 -1 O VAL A 164 N ALA A 72 SSBOND 1 CYS A 71 CYS A 159 1555 1555 2.05 SSBOND 2 CYS A 74 CYS A 146 1555 1555 2.02 SSBOND 3 CYS A 77 CYS A 166 1555 1555 2.02 SSBOND 4 CYS A 259 CYS A 262 1555 1555 2.08 CRYST1 39.155 178.226 139.595 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025540 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005611 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007164 0.00000